Imran Talat (CIK 1869579) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-21). Recent activity: Buy RANI (35,000 shares), Sell RANI (8,014 shares), Sell RANI (9,076 shares), Sell RANI (9,077 shares), Sell RANI (7,906 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-21 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Executive Officer | Buy | 35,000 | $25,193 |
| 2026-07-21 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Executive Officer | Sell | 8,014 | $11,300 |
| 2026-07-21 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Executive Officer | Sell | 9,076 | $4,992 |
| 2026-07-21 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Executive Officer | Sell | 9,077 | $4,357 |
| 2026-07-21 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Executive Officer | Sell | 7,906 | $11,068 |
| 2026-07-21 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Executive Officer | Sell | 8,916 | $10,075 |
| 2026-07-21 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Executive Officer | Sell | 9,099 | $7,370 |
| 2026-07-21 | Rani Therapeutics Holdings, Inc. (RANI) | Chief Executive Officer | Sell | 7,927 | $5,866 |
Source: SEC Form 4 filings · as of 2026-07-21